KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Retained Earnings: 2009-2024

Historic Retained Earnings for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $5.3 billion.

  • Idexx Laboratories' Retained Earnings rose 20.08% to $6.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 billion, marking a year-over-year increase of 20.08%. This contributed to the annual value of $5.3 billion for FY2024, which is 19.98% up from last year.
  • Per Idexx Laboratories' latest filing, its Retained Earnings stood at $5.3 billion for FY2024, which was up 19.98% from $4.4 billion recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Retained Earnings ranged from a high of $5.3 billion in FY2024 and a low of $2.2 billion during FY2020.
  • Its 3-year average for Retained Earnings is $4.5 billion, with a median of $4.4 billion in 2023.
  • Data for Idexx Laboratories' Retained Earnings shows a peak YoY skyrocketed of 36.35% (in 2020) over the last 5 years.
  • Idexx Laboratories' Retained Earnings (Yearly) stood at $2.2 billion in 2020, then surged by 34.24% to $2.9 billion in 2021, then climbed by 23.25% to $3.6 billion in 2022, then rose by 23.48% to $4.4 billion in 2023, then grew by 19.98% to $5.3 billion in 2024.